Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages

  Howard, Brandi ^a   Wang, Yonghong ^a   Xekouki, Paraskevi ^b   Faucz, Fabio R ^b   Jain, Meenu ^a   Zhang, Lisa ^a   Meltzer, Paul G ^a   Stratakis, Constantine A ^b   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; DNA;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ADRENAL CORTEX TUMOR; ADULT; AGED; ALDOSTERONOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYP11B2 GENE; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETIC REPRESSION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PRKCA GENE; PROMOTER REGION; STEROIDOGENESIS; UPREGULATION;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; SYSTEMS INTEGRATION; YOUNG ADULT;

EID: 84895780607     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3495     Document Type: Article

References (25)

1. Chao CT, Wu VC, Kuo CC, et al. Diagnosis and management of primary aldosteronism: an updated review. Ann Med. 2013;45:375-383.
2. Zennaro MC, Jeunemaitre X, Boulkroun S. Integrating genetics and genomics in primary aldosteronism. Hypertension. 2012;60:580-588.
3. Bird IM, Hanley NA, Word RA, et al. Human NCI-H295 adreno-cortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology. 1993;133:1555-1561. (Pubitemid 23295179)
4. Bassett MH, Mayhew B, Rehman K, et al. Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab. 2005;90:5446-5455. (Pubitemid 41262314)
5. Xekouki P, Hatch MM, Lin L, et al. KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. Endocr Relat Cancer. 2012;19:255-260.
6. Scholl UI, Nelson-Williams C, Yue P, et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A. 2012;109:2533-2538.
7. Taguchi R, Yamada M, Nakajima Y, et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab. 2012;97:1311-1319.
8. + channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
9. Monticone S, Hattangady NG, Nishimoto K, et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab. 2012;97:E1567-E1572.
10. Boulkroun S, Beuschlein F, Rossi GP, et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension. 2012;59:592-598.
11. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440-444, 444e441-442.
12. Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055-1060.
13. Scholl UI, Goh G, Stölting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050-1054.
14. Shibata H, Ando T, Suzuki T, et al. COUP-TFI expression in human adrenocortical adenomas: possible role in steroidogenesis. J Clin Endocrinol Metab. 1998;83:4520-4523. (Pubitemid 29100161)
15. Perraudin V, Delarue C, Lefebvre H, Do Rego JL, Vaudry H, Kuhn JM. Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. J Clin Endocrinol Metab. 2006;91:1566-1572.
16. Grazzini E, Boccara G, Joubert D, et al. Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. Adv Exp Med Biol. 1998;449:325-334. (Pubitemid 28566404)
17. Guillon G, Trueba M, Joubert D, et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology. 1995;136:1285-1295.
18. Brizuela L, Rabano M, Pena A, et al. Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion. J Lipid Res. 2006;47:1238-1249. (Pubitemid 43830716)
19. Pascale RM, Simile MM, De Miglio MR, Feo F. Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine. Alcohol. 2002;27:193-198. (Pubitemid 34876922)
20. LeHoux JG, Dupuis G, Lefebvre A. Regulation of CYP11B2 gene expression by protein kinase C. Endocr Res. 2000;26:1027-1031. (Pubitemid 32053137)
21. Shah BH, Baukal AJ, Shah FB, Catt KJ. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor. Mol Endocrinol. 2005;19:2535-2548. (Pubitemid 41362667)
22. Campbell PM, Bovenzi V, Szyf M. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis. 2004;25:499-507. (Pubitemid 38499940)
23. Osswald A, Fischer E, Degenhart C, et al. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenomas. Eur J Endocrinol. 2013;169:657-663.
24. Enberg U, Volpe C, Höög A, et al. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol. 2004;151:73-85. (Pubitemid 39117367)
25. Boulkroun S, Samson-Couterie B, Golib-Dzib JF, et al. Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. Endocrinology. 2011;152:4753-4763.